0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Terlipressin for Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17F14861
Home | Market Reports | Health| Pharmacy
Global Terlipressin for Injection Market Research Report 2023
BUY CHAPTERS

Global Terlipressin for Injection Market Research Report 2025

Code: QYRE-Auto-17F14861
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Terlipressin for Injection Market

The global market for Terlipressin for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.
North American market for Terlipressin for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Terlipressin for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Terlipressin for Injection include Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure, Criticine Care, Integrated Laboratories Pvt Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Terlipressin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terlipressin for Injection.
The Terlipressin for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Terlipressin for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terlipressin for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Terlipressin for Injection Market Report

Report Metric Details
Report Name Terlipressin for Injection Market
Segment by Type
  • Lumps
  • Powder
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure, Criticine Care, Integrated Laboratories Pvt Ltd, Hybio Pharmaceutical Co., Ltd, Fujian Mindong Rejuenation Pharmaceutical Co., Ltd, Hangzhou Ausia Biological Technology Company, Ltd, Nanjing Kangzhou Pharmaceutical Technology Co., Ltd, Hainan General Sanyang Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Terlipressin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Terlipressin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Terlipressin for Injection Market report?

Ans: The main players in the Terlipressin for Injection Market are Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure, Criticine Care, Integrated Laboratories Pvt Ltd, Hybio Pharmaceutical Co., Ltd, Fujian Mindong Rejuenation Pharmaceutical Co., Ltd, Hangzhou Ausia Biological Technology Company, Ltd, Nanjing Kangzhou Pharmaceutical Technology Co., Ltd, Hainan General Sanyang Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Terlipressin for Injection Market report?

Ans: The Applications covered in the Terlipressin for Injection Market report are Internal Medicine Application, surgical application, Intensive Care Unit (ICU) Applications

What are the Type segmentation covered in the Terlipressin for Injection Market report?

Ans: The Types covered in the Terlipressin for Injection Market report are Lumps, Powder

Recommended Reports

Injection Drug Markets

Hormones & Antidiuretic

Shock & Blood Pressure

1 Terlipressin for Injection Market Overview
1.1 Product Definition
1.2 Terlipressin for Injection by Type
1.2.1 Global Terlipressin for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lumps
1.2.3 Powder
1.3 Terlipressin for Injection by Application
1.3.1 Global Terlipressin for Injection Market Value by Application (2024 VS 2031)
1.3.2 Internal Medicine Application
1.3.3 surgical application
1.3.4 Intensive Care Unit (ICU) Applications
1.4 Global Terlipressin for Injection Market Size Estimates and Forecasts
1.4.1 Global Terlipressin for Injection Revenue 2020-2031
1.4.2 Global Terlipressin for Injection Sales 2020-2031
1.4.3 Global Terlipressin for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Terlipressin for Injection Market Competition by Manufacturers
2.1 Global Terlipressin for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Terlipressin for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Terlipressin for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Terlipressin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terlipressin for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terlipressin for Injection, Product Type & Application
2.7 Global Key Manufacturers of Terlipressin for Injection, Date of Enter into This Industry
2.8 Global Terlipressin for Injection Market Competitive Situation and Trends
2.8.1 Global Terlipressin for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Terlipressin for Injection Players Market Share by Revenue
2.8.3 Global Terlipressin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Terlipressin for Injection Market Scenario by Region
3.1 Global Terlipressin for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Terlipressin for Injection Sales by Region: 2020-2031
3.2.1 Global Terlipressin for Injection Sales by Region: 2020-2025
3.2.2 Global Terlipressin for Injection Sales by Region: 2026-2031
3.3 Global Terlipressin for Injection Revenue by Region: 2020-2031
3.3.1 Global Terlipressin for Injection Revenue by Region: 2020-2025
3.3.2 Global Terlipressin for Injection Revenue by Region: 2026-2031
3.4 North America Terlipressin for Injection Market Facts & Figures by Country
3.4.1 North America Terlipressin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Terlipressin for Injection Sales by Country (2020-2031)
3.4.3 North America Terlipressin for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Terlipressin for Injection Market Facts & Figures by Country
3.5.1 Europe Terlipressin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Terlipressin for Injection Sales by Country (2020-2031)
3.5.3 Europe Terlipressin for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terlipressin for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Terlipressin for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Terlipressin for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Terlipressin for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Terlipressin for Injection Market Facts & Figures by Country
3.7.1 Latin America Terlipressin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Terlipressin for Injection Sales by Country (2020-2031)
3.7.3 Latin America Terlipressin for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terlipressin for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Terlipressin for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Terlipressin for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Terlipressin for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terlipressin for Injection Sales by Type (2020-2031)
4.1.1 Global Terlipressin for Injection Sales by Type (2020-2025)
4.1.2 Global Terlipressin for Injection Sales by Type (2026-2031)
4.1.3 Global Terlipressin for Injection Sales Market Share by Type (2020-2031)
4.2 Global Terlipressin for Injection Revenue by Type (2020-2031)
4.2.1 Global Terlipressin for Injection Revenue by Type (2020-2025)
4.2.2 Global Terlipressin for Injection Revenue by Type (2026-2031)
4.2.3 Global Terlipressin for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Terlipressin for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Terlipressin for Injection Sales by Application (2020-2031)
5.1.1 Global Terlipressin for Injection Sales by Application (2020-2025)
5.1.2 Global Terlipressin for Injection Sales by Application (2026-2031)
5.1.3 Global Terlipressin for Injection Sales Market Share by Application (2020-2031)
5.2 Global Terlipressin for Injection Revenue by Application (2020-2031)
5.2.1 Global Terlipressin for Injection Revenue by Application (2020-2025)
5.2.2 Global Terlipressin for Injection Revenue by Application (2026-2031)
5.2.3 Global Terlipressin for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Terlipressin for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ferring Pharmaceuticals
6.1.1 Ferring Pharmaceuticals Company Information
6.1.2 Ferring Pharmaceuticals Description and Business Overview
6.1.3 Ferring Pharmaceuticals Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ferring Pharmaceuticals Terlipressin for Injection Product Portfolio
6.1.5 Ferring Pharmaceuticals Recent Developments/Updates
6.2 Ranbaxy UK Ltd
6.2.1 Ranbaxy UK Ltd Company Information
6.2.2 Ranbaxy UK Ltd Description and Business Overview
6.2.3 Ranbaxy UK Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ranbaxy UK Ltd Terlipressin for Injection Product Portfolio
6.2.5 Ranbaxy UK Ltd Recent Developments/Updates
6.3 TAJ LIFE SCIENCES
6.3.1 TAJ LIFE SCIENCES Company Information
6.3.2 TAJ LIFE SCIENCES Description and Business Overview
6.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TAJ LIFE SCIENCES Terlipressin for Injection Product Portfolio
6.3.5 TAJ LIFE SCIENCES Recent Developments/Updates
6.4 Mallinckrodt plc
6.4.1 Mallinckrodt plc Company Information
6.4.2 Mallinckrodt plc Description and Business Overview
6.4.3 Mallinckrodt plc Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mallinckrodt plc Terlipressin for Injection Product Portfolio
6.4.5 Mallinckrodt plc Recent Developments/Updates
6.5 EVER Pharma
6.5.1 EVER Pharma Company Information
6.5.2 EVER Pharma Description and Business Overview
6.5.3 EVER Pharma Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 EVER Pharma Terlipressin for Injection Product Portfolio
6.5.5 EVER Pharma Recent Developments/Updates
6.6 Alliance Pharmaceuticals
6.6.1 Alliance Pharmaceuticals Company Information
6.6.2 Alliance Pharmaceuticals Description and Business Overview
6.6.3 Alliance Pharmaceuticals Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alliance Pharmaceuticals Terlipressin for Injection Product Portfolio
6.6.5 Alliance Pharmaceuticals Recent Developments/Updates
6.7 Serum Institute of India Pvt. Ltd
6.7.1 Serum Institute of India Pvt. Ltd Company Information
6.7.2 Serum Institute of India Pvt. Ltd Description and Business Overview
6.7.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Serum Institute of India Pvt. Ltd Terlipressin for Injection Product Portfolio
6.7.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
6.8 Biovenice Criticure
6.8.1 Biovenice Criticure Company Information
6.8.2 Biovenice Criticure Description and Business Overview
6.8.3 Biovenice Criticure Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biovenice Criticure Terlipressin for Injection Product Portfolio
6.8.5 Biovenice Criticure Recent Developments/Updates
6.9 Criticine Care
6.9.1 Criticine Care Company Information
6.9.2 Criticine Care Description and Business Overview
6.9.3 Criticine Care Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Criticine Care Terlipressin for Injection Product Portfolio
6.9.5 Criticine Care Recent Developments/Updates
6.10 Integrated Laboratories Pvt Ltd
6.10.1 Integrated Laboratories Pvt Ltd Company Information
6.10.2 Integrated Laboratories Pvt Ltd Description and Business Overview
6.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Integrated Laboratories Pvt Ltd Terlipressin for Injection Product Portfolio
6.10.5 Integrated Laboratories Pvt Ltd Recent Developments/Updates
6.11 Hybio Pharmaceutical Co., Ltd
6.11.1 Hybio Pharmaceutical Co., Ltd Company Information
6.11.2 Hybio Pharmaceutical Co., Ltd Description and Business Overview
6.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Product Portfolio
6.11.5 Hybio Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
6.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Information
6.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Description and Business Overview
6.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Product Portfolio
6.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments/Updates
6.13 Hangzhou Ausia Biological Technology Company, Ltd
6.13.1 Hangzhou Ausia Biological Technology Company, Ltd Company Information
6.13.2 Hangzhou Ausia Biological Technology Company, Ltd Description and Business Overview
6.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Product Portfolio
6.13.5 Hangzhou Ausia Biological Technology Company, Ltd Recent Developments/Updates
6.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
6.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Information
6.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Description and Business Overview
6.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Product Portfolio
6.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments/Updates
6.15 Hainan General Sanyang Pharmaceutical Co., Ltd
6.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Company Information
6.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Product Portfolio
6.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terlipressin for Injection Industry Chain Analysis
7.2 Terlipressin for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terlipressin for Injection Production Mode & Process Analysis
7.4 Terlipressin for Injection Sales and Marketing
7.4.1 Terlipressin for Injection Sales Channels
7.4.2 Terlipressin for Injection Distributors
7.5 Terlipressin for Injection Customer Analysis
8 Terlipressin for Injection Market Dynamics
8.1 Terlipressin for Injection Industry Trends
8.2 Terlipressin for Injection Market Drivers
8.3 Terlipressin for Injection Market Challenges
8.4 Terlipressin for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Terlipressin for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Terlipressin for Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Terlipressin for Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Terlipressin for Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Terlipressin for Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Terlipressin for Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Terlipressin for Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Terlipressin for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Terlipressin for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Terlipressin for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Terlipressin for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Terlipressin for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Terlipressin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terlipressin for Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Terlipressin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Terlipressin for Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Terlipressin for Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Terlipressin for Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Terlipressin for Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Terlipressin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Terlipressin for Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Terlipressin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Terlipressin for Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Terlipressin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Terlipressin for Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Terlipressin for Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Terlipressin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Terlipressin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Terlipressin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Terlipressin for Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Terlipressin for Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Terlipressin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Terlipressin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Terlipressin for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Terlipressin for Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Terlipressin for Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Terlipressin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Terlipressin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Terlipressin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Terlipressin for Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Terlipressin for Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Terlipressin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Terlipressin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Terlipressin for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Terlipressin for Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Terlipressin for Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Terlipressin for Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Terlipressin for Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Terlipressin for Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Terlipressin for Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Terlipressin for Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Terlipressin for Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Terlipressin for Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Terlipressin for Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Terlipressin for Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Terlipressin for Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Terlipressin for Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Terlipressin for Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Terlipressin for Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Terlipressin for Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Terlipressin for Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Terlipressin for Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Terlipressin for Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Terlipressin for Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Terlipressin for Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Terlipressin for Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Terlipressin for Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Terlipressin for Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Ferring Pharmaceuticals Company Information
 Table 71. Ferring Pharmaceuticals Description and Business Overview
 Table 72. Ferring Pharmaceuticals Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Ferring Pharmaceuticals Terlipressin for Injection Product
 Table 74. Ferring Pharmaceuticals Recent Developments/Updates
 Table 75. Ranbaxy UK Ltd Company Information
 Table 76. Ranbaxy UK Ltd Description and Business Overview
 Table 77. Ranbaxy UK Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ranbaxy UK Ltd Terlipressin for Injection Product
 Table 79. Ranbaxy UK Ltd Recent Developments/Updates
 Table 80. TAJ LIFE SCIENCES Company Information
 Table 81. TAJ LIFE SCIENCES Description and Business Overview
 Table 82. TAJ LIFE SCIENCES Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TAJ LIFE SCIENCES Terlipressin for Injection Product
 Table 84. TAJ LIFE SCIENCES Recent Developments/Updates
 Table 85. Mallinckrodt plc Company Information
 Table 86. Mallinckrodt plc Description and Business Overview
 Table 87. Mallinckrodt plc Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mallinckrodt plc Terlipressin for Injection Product
 Table 89. Mallinckrodt plc Recent Developments/Updates
 Table 90. EVER Pharma Company Information
 Table 91. EVER Pharma Description and Business Overview
 Table 92. EVER Pharma Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. EVER Pharma Terlipressin for Injection Product
 Table 94. EVER Pharma Recent Developments/Updates
 Table 95. Alliance Pharmaceuticals Company Information
 Table 96. Alliance Pharmaceuticals Description and Business Overview
 Table 97. Alliance Pharmaceuticals Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Alliance Pharmaceuticals Terlipressin for Injection Product
 Table 99. Alliance Pharmaceuticals Recent Developments/Updates
 Table 100. Serum Institute of India Pvt. Ltd Company Information
 Table 101. Serum Institute of India Pvt. Ltd Description and Business Overview
 Table 102. Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Serum Institute of India Pvt. Ltd Terlipressin for Injection Product
 Table 104. Serum Institute of India Pvt. Ltd Recent Developments/Updates
 Table 105. Biovenice Criticure Company Information
 Table 106. Biovenice Criticure Description and Business Overview
 Table 107. Biovenice Criticure Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biovenice Criticure Terlipressin for Injection Product
 Table 109. Biovenice Criticure Recent Developments/Updates
 Table 110. Criticine Care Company Information
 Table 111. Criticine Care Description and Business Overview
 Table 112. Criticine Care Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Criticine Care Terlipressin for Injection Product
 Table 114. Criticine Care Recent Developments/Updates
 Table 115. Integrated Laboratories Pvt Ltd Company Information
 Table 116. Integrated Laboratories Pvt Ltd Description and Business Overview
 Table 117. Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Integrated Laboratories Pvt Ltd Terlipressin for Injection Product
 Table 119. Integrated Laboratories Pvt Ltd Recent Developments/Updates
 Table 120. Hybio Pharmaceutical Co., Ltd Company Information
 Table 121. Hybio Pharmaceutical Co., Ltd Description and Business Overview
 Table 122. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Product
 Table 124. Hybio Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 125. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Information
 Table 126. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Description and Business Overview
 Table 127. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Product
 Table 129. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 130. Hangzhou Ausia Biological Technology Company, Ltd Company Information
 Table 131. Hangzhou Ausia Biological Technology Company, Ltd Description and Business Overview
 Table 132. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Product
 Table 134. Hangzhou Ausia Biological Technology Company, Ltd Recent Developments/Updates
 Table 135. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Information
 Table 136. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Description and Business Overview
 Table 137. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Product
 Table 139. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments/Updates
 Table 140. Hainan General Sanyang Pharmaceutical Co., Ltd Company Information
 Table 141. Hainan General Sanyang Pharmaceutical Co., Ltd Description and Business Overview
 Table 142. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Product
 Table 144. Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Terlipressin for Injection Distributors List
 Table 148. Terlipressin for Injection Customers List
 Table 149. Terlipressin for Injection Market Trends
 Table 150. Terlipressin for Injection Market Drivers
 Table 151. Terlipressin for Injection Market Challenges
 Table 152. Terlipressin for Injection Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Terlipressin for Injection
 Figure 2. Global Terlipressin for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Terlipressin for Injection Market Share by Type: 2024 & 2031
 Figure 4. Lumps Product Picture
 Figure 5. Powder Product Picture
 Figure 6. Global Terlipressin for Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Terlipressin for Injection Market Share by Application: 2024 & 2031
 Figure 8. Internal Medicine Application
 Figure 9. surgical application
 Figure 10. Intensive Care Unit (ICU) Applications
 Figure 11. Global Terlipressin for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Terlipressin for Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Terlipressin for Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Terlipressin for Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Terlipressin for Injection Report Years Considered
 Figure 16. Terlipressin for Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Terlipressin for Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Terlipressin for Injection Players: Market Share by Revenue in Terlipressin for Injection in 2024
 Figure 19. Terlipressin for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Terlipressin for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Terlipressin for Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Terlipressin for Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Terlipressin for Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Terlipressin for Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Terlipressin for Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Terlipressin for Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Terlipressin for Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Terlipressin for Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Terlipressin for Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Terlipressin for Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Terlipressin for Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Terlipressin for Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Terlipressin for Injection by Type (2020-2031)
 Figure 53. Global Terlipressin for Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Terlipressin for Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Terlipressin for Injection by Application (2020-2031)
 Figure 56. Global Terlipressin for Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Terlipressin for Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart